Drug Type Small molecule drug |
Synonyms next generation galeterone analogs (Univ Maryland) |
Target |
Action antagonists, inhibitors, modulators |
Mechanism AR antagonists(Androgen Receptor antagonists), CYPs inhibitors(Cytochrome P450 inhibitors), EIF4E3 modulators(eukaryotic translation initiation factor 4E family member 3 modulators) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Cancer | Preclinical | United States | - | |
| Castration-Resistant Prostatic Cancer | Discovery | United States | - |





